Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tracy B Bramlette

Showing results (1-10 of 3) with videos related to

Pageof 1
Sort By:
Dermatologic Surgery : Official Publication for American Society for Dermatologic Surgery [Et Al.]|May 14, 2016
The Paramidline Forehead Flap: A Clinical and Microanatomic StudyLandon E Stigall, Tracy B Bramlette, John A Zitelli, et al.
Dermatologic Surgery : Official Publication for American Society for Dermatologic Surgery [Et Al.]|September 10, 2009
Mohs versus traditional surgical excision for facial and auricular nonmelanoma skin cancer: an analysis of cost-effectivenessAnne M Seidler, Tracy B Bramlette, Carl V Washington, et al.
Dermatologic Surgery : Official Publication for American Society for Dermatologic Surgery [Et Al.]|January 12, 2007
Interferon Alfa-2b or not 2b? Significant differences exist in the decision-making process between melanoma patients who accept or decline high-dose adjuvant interferon Alfa-2b treatmentTracy B Bramlette, David H Lawson, Carl V Washington, et al.
Pageof 1

Showing results (1-10 of 3) with videos related to

Sort By:
Pageof 1
Dermatologic Surgery : Official Publication for American Society for Dermatologic Surgery [Et Al.]|May 14, 2016
The Paramidline Forehead Flap: A Clinical and Microanatomic StudyLandon E Stigall, Tracy B Bramlette, John A Zitelli, et al.
Dermatologic Surgery : Official Publication for American Society for Dermatologic Surgery [Et Al.]|September 10, 2009
Mohs versus traditional surgical excision for facial and auricular nonmelanoma skin cancer: an analysis of cost-effectivenessAnne M Seidler, Tracy B Bramlette, Carl V Washington, et al.
Dermatologic Surgery : Official Publication for American Society for Dermatologic Surgery [Et Al.]|January 12, 2007
Interferon Alfa-2b or not 2b? Significant differences exist in the decision-making process between melanoma patients who accept or decline high-dose adjuvant interferon Alfa-2b treatmentTracy B Bramlette, David H Lawson, Carl V Washington, et al.
Pageof 1